A Safety and Efficacy Study of a Recombinant Factor IX in Patients With Severe Hemophilia B
Clinical trial NCT01361126 · COMPLETED
Trial details
- NCT number
- NCT01361126
- Sponsor
- CSL Behring
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2012-06-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.